Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-Controlled Trial of Ethyl-EPA (Miraxion™) in Subjects With Mild to Moderate Huntington's Disease

NCT00146211 is registered in ClinicalTrials.gov with Amarin Neuroscience Ltd as lead sponsor.

NCT NCT00146211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-Controlled Trial of Ethyl-EPA (Miraxion™) in Subjects With Mild to Moderate Huntington's Disease
Lead sponsor
Amarin Neuroscience Ltd
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
July 31, 2007
Enrollment
300 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

huntington disease